| Literature DB >> 16242045 |
Yuko Taniguchi1, Kisato Nosaka, Jun-ichirou Yasunaga, Michiyuki Maeda, Nancy Mueller, Akihiko Okayama, Masao Matsuoka.
Abstract
BACKGROUND: Human T-cell leukemia virus type I (HTLV-I) causes adult T-cell leukemia (ATL) after a long latent period. Among accessory genes encoded by HTLV-I, the tax gene is thought to play a central role in oncogenesis. However, Tax expression is disrupted by several mechanims including genetic changes of the tax gene, deletion/hypermethylation of 5'-LTR. To clarify the role of epigenetic changes, we analyzed DNA methylation and histone modification in the whole HTLV-I provirus genome.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16242045 PMCID: PMC1289293 DOI: 10.1186/1742-4690-2-64
Source DB: PubMed Journal: Retrovirology ISSN: 1742-4690 Impact factor: 4.602
Figure 1DNA methylation of the HTLV-I provirus assessed by sodium bisulfite sequencing and COBRA. A. DNA methylation in the HTLV-I provirus was analyzed by sodium bisulfite sequencing in a case of acute ATL and a tax gene-expressing cell line, ATL-48T. Eight DNA regions, which were represented as bars in A, were amplified with sodium bisulfite treated DNA. The PCR products were subcloned into plasmid DNA, and then the sequences of each clone were determined for at least ten clones of each region. Arrowheads indicate the CpG sites that were target sites for COBRA. Closed circle indicates methylated CpG, and open circle means unmethylated CpG. The number of integrated provirus has been shown in parenthesis. B. Representative data of COBRA has been shown. PCR products, which were amplified with sodium bisulfite treated DNAs, were digested with TaqI or AccII. The extent of methylation in each CpG site was measured as described in Methods, and presented as percentages of methylated CpG. The number in parenthesis represents the position of cytidine residue in analyzed CpG site by COBRA according to Seiki et al. [41]. C. DNA methylation studied by COBRA at eight points in the provirus as shown by arrowheads. Each bar represented the extent of DNA methylation at the points shown by arrowhead. The analyses by COBRA were performed three times independently, and the extents of DNA methylation are shown by the mean ± SD. The number in parenthesis shows the position of cytidine residue of CpG site analyzed by COBRA.
Figure 2DNA methylation in ATL cell lines, HTLV-I carriers and ATL cases. The tax gene transcription in ATL cell lines was studied by RT-PCR (A), and the expression of GAPDH gene has been used as a control. DNA methylation throughout the HTLV-I provirus was studied by COBRA in tax gene-expressing (B) and non-expressing cell lines (C). Furthermore, DNA methylation was also analyzed in 20 carriers and 20 ATL cases by COBRA, and representative patterns of DNA methylation are shown in D. The number of HTLV-I provirus has been analyzed by Southern blot method, and shown in the parenthesis (B, C and D). Each bar indicates the extent of DNA methylation that was calculated by COBRA.
Figure 3Comparison of the DNA methylation in carriers and ATL cases. A. DNA methylation at eight different regions in the HTLV-I provirus was compared between carriers (C) and ATL cases (A). DNA methylation was quantified by COBRA in 20 carriers and 20 ATL cases. Each sample was analyzed three times by COBRA at each site, and circles indicate mean values of DNA methylation. The differences of DNA methylation are statistically significant in the gag, pol and env regions by the Mann-Whitney's U-test. Horizontal bars represent median of DNA methylation in each group. B. The relation between tax gene transcription and DNA methylation of 5'-LTR in the fresh ATL cells has been shown. DNA methylation of 5'-LTR was quantified by COBRA assay and the tax gene transcripts were detected by RT-PCR.
Figure 4Sequential analyses of the DNA methylation in seroconverters and a cell line. DNA methylation was analyzed by COBRA in sequential samples from seroconverters (A) and in a cell line, ATL-21C, (B) cultured in vitro for more than 9 years. DNA methylation was analysed by COBRA three times, and each bar indicates mean ± SD.
Figure 5DNA methylation of provirus is not associated with methylated CpG sites in the genome. Integration sites of HTLV-I provirus in leukemic cells have been determined by inverse PCR, and then DNA methylation in genome has been analyzed by sodium bisulfite sequencing. DNA methylation of 5'-LTR was also analyzed by sodium bisulfite sequencing method. Vertical bars represent CpG sites. Open circle indicates unmethylated CpG site, and closed one means methylated CpG site. N: normal PBMCs from non-carrier donor.
Figure 6Histone modifications in ATL cell lines. Acetylation of histone was analyzed in tax gene-expressing (ATL-48T) and non-expressing (ATL-43T) cell lines by ChIP assays with anti-acetyl-Histone H3 or H4 (A and B) at four different regions (for 5'-LTR, env, pX and 3'-LTR) of the provirus. Representative data has been shown in A. W.C.E.: whole cell extract. ChIP assay was performed three times and quantified as described in Methods. Values are means ± SD(B). *:p < 0.002.
Figure 7DNA methylation and histone modifications in fresh ATL cases. A. The relationships among DNA methylation, tax gene expression and histone modification in 5'-LTR were analyzed in three ATL cases. Cases 1 and 3 have one copy of the complete HTLV-I provirus, while Case 2 has a defective provirus that lacks part of the pol gene. DNA methylation was analyzed by COBRA. The tax gene transcripts could be detected in Case 1, but not in Cases 2 or 3, by RT-PCR. ChIP assays were also performed using primers for 5'-LTR to analyze acetylation of histone H3 (Ac-H3) and H4 (Ac-H4). W.C.E.: whole cell extract. B. Recovery of tax gene expression ex vivo. The PBMCs isolated from Case 3 were immediately cultured ex vivo for several hours and tested the transcription of tax mRNA by RT-PCR.
Primer sets for COBRA and ChIP assay
| Site in HTLV-Ia | Forward primer | Reverse primer | Anneal (°C) | Enzyme for COBRA | ||
| COBRA | 620 | 1st | 5'-TTTGGAGTTTATTTAGATTTAG-3' | 5'-CCAATAATAAACRACCAACCC-3' | 45 | |
| (5'-LTR) | 2nd | 5'-GTTTTGTTTGATTTTGTTTGT-3' | 5'-AAAAAAATTTAACCCATTACC-3' | 49 | ||
| 1753 | 1st | 5'-GGGAGTGTTAAAGATTTTTTTTGGG-3' | 5'-ACTCCAATAACCTACTTTCCC-3' | 55 | ||
| ( | 2nd | 5'-TTTATTTTTTAAGGTTTGGAGGAG-3' | 5'-TTAAAAATCCAAATCTAACAAACCC-3' | 55 | ||
| 2988 | 1st | 5'-GTTAAAAAGGTTAATGGAATTTGG-3' | 5'-CCTCTAAAAATAATAATAAATCCTC-3' | 52 | ||
| ( | 2nd | 5'-GGGTTTTTTGATTTGTTTAGTTTG-3' | 5'-AAACTTACTAAAAAAATATCATCC-3' | 51 | ||
| 4187 | 1st | 5'-GGGTGAAATTGTGTAGTTTTGTAGG-3' | 5'-CCTATTTTCAAACGAATCTACCTCC-3' | 57 | ||
| ( | 2nd | 5'-GTGATTAGTAGGGTATTTGTGAGAG-3' | 5'-ATTATCACAAAAATCATTCCCCC-3' | 52 | ||
| 5151 | 1st | 5'-GGTATTATTTTAAGTTTTTTGG-3' | 5'-CTCCAATTATAAAAATACAACAAC-3' | 46 | ||
| ( | 2nd | 5'-GTTAGTGGAAAGGATTATAGGAGG-3' | 5'-AACTTACCCATAATATTAAAAATC-3' | 51 | ||
| 6113 | 1st | 5'-GGATTTATTGTTTTGATTTTTAG-3' | 5'-CTTTACATAATCCTCCTTACTCCC-3' | 51 | ||
| ( | 2nd | 5'-GGATTTATTGTTTTGATTTTTAG-3' | 5'-CCCAAAACAAAAAATCAAAACC-3' | 53 | ||
| 7258 | 1st | 5'-GAGGTGGYGTTTTTTTTTTTGG-3' | 5'-CCTTAAAAATCTTAAAAATTCTC-3' | 47 | ||
| (pX) | 2nd | 5'-AAGGATAGTAAATYGTTAAGTATAG-3' | 5'-CCCAAATAATCTAATACTCTAAAC-3' | 50 | ||
| 8342 | 1st | 5'-YGATGGTAYGTTTATGATTTTYGGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 57 | ||
| (3'-LTR) | 2nd | 5'-YGATGGTAYGTTTATGATTTTYGGG-3' | 5'-AACTCCTACTAATTTATTAAACC-3' | 52 | ||
| 5'-LTRb | 5'-GCTTTGCCTGACCCTGCTTGC-3' | 5'-AAGATTTGGCCCATTGCCTAGGG-3' | 63 | |||
| 5'-TGCCAGCCTCTCCACTTGGCACG-3' | 5'-ATGGAGCCGGTAATCCCGCCAGC-3' | 64 | ||||
| pX | 5'-AAGGATAGCAAACCGTCAAGCACAG-3' | 5'-CCCAGGTGATCTGATGCTCTGGAC-3' | 63 | |||
| 3'-LTR | 5'-CCCCTCATTTCTACTCTCACACGGC-3' | 5'-TGGGTGGTTCTTGGTGGCTTCCC-3' | 64 |
a Nucleotide position corresponding to that of ATK. This number means the cytidine of CpG sites analysed.
bFor ChIP assay, we used primers to amplify the indicated regions.
Primer sets and annealing temperatures for genome specific PCR
| Case | Locus | Forward primer | Reverse primer | Anneal (°C) | ||
| Primers for case | Acute ATL 1 | 5q11.1 | 1st | 5'-TTTGGAGAGGGAATTTTATATTG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 55 |
| 2nd | 5'-GGAGTGTAGAGATGTAGTTTTGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 50 | |||
| Acute ATL 2 | 8p23.1 | 1st | 5'-GAGAAATTTGTGTTGATTTTATTAG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 47 | |
| 2nd | 5'-TTAGTGGTAGATTAAGTTAAAG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 45 | |||
| Acute ATL 3 | 1q31.1 | 1st | 5'-GGTAGAAATTATAGGTTTTTGTAGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 51 | |
| 2nd | 5'-GTTATTTGTGAAGTAAGATGTTTTG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 53 | |||
| Acute ATL 21 | 15q24.3 | 1st | 5'-GAGGTGGATTTTTATTTTATTG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 52 | |
| 2nd | 5'-GGTTTTTGATTATATTTGGGGAG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 54 | |||
| Acute ATL 22 | 19q13.11 | 1st | 5'-GTTAGTTGTTAGAGAGTTTTTTGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 52 | |
| 2nd | 5'-AAGATTATTTAGTTTTTTGGGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 54 | |||
| Chronic ATL 1 | 1p22.1 | 1st | 5'-GGGTTTGAAGTTTTTTTTGTAGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' | 53 | |
| 2nd | 5'-AAGATTATTTAGTTTTTTGGGG-3' | 5'-ACCCCCTCCTAAACTATCTCC-3' (5'-LTR U3) | 50 | |||
| Primers for human genome | 5q11.1 | 1st | 5'-TTTGGAGAGGGAATTTTATATTG-3' | 5'-CCCAAACTAATCTTCAACTCC-3' | 52 | |
| 2nd | 5'-GGAGTGTAGAGATGTAGTTTTGG-3' | 5'-CCACCATAAAAAACCCTCCC-3' | 54 | |||
| 8p23.1 | 1st | 5'-GAGAAATTTGTGTTGATTTTATTAG-3' | 5'-AATATCACTATAACAATAACCAC-3' | 46 | ||
| 2nd | 5'-TTAGTGGTAGATTAAGTTAAAG-3' | 5'-CTCTCAACAAATTCCATCTTTCC-3' | 49 | |||
| 1q31.1 | 1st | 5'-GGTAGAAATTATAGGTTTTTGTAGG-3' | 5'-CACCATTAAACAAACTAAATTCTC-3' | 51 | ||
| 2nd | 5'-GTTATTTGTGAAGTAAGATGTTTTG-3' | 5'-CACATAAAAAAACCCACACAATC-3' | 53 | |||
| 15q24.3 | 1st | 5'-GAGGTGGATTTTTATTTTATTG-3' | 5'-ATCTACCTAAAAAACCCACCC-3' | 52 | ||
| 2nd | 5'-GGTTTTTGATTATATTTGGGGAG-3' | 5'-AAAAACCCACCCAAACAAACC-3' | 57 | |||
| 19q13.11 | 1st | 5'-GTTAGTTGTTAGAGAGTTTTTTGG-3' | 5'-CAACTCCCTAAACCCTCCTCC-3' | 52 | ||
| 2nd | 5'-GTTTTTTGGTTAAGGTTATGGG-3' | 5'-CTCCTACCACGAACCTACTCC-3' | 54 | |||
| 1p22.1 | 1st | 5'-GGGTTTGAAGTTTTTTTTGTAGG-3' | 5'-CAACAAAAACAATAAACAAAACC-3' | 54 | ||
| 2nd | 5'-AAGATTATTTAGTTTTTTGGGG-3' | 5'-CTTTACACCAATAAATTTAATACC-3' | 50 |